Novartis to expand neuroscience portfolio with $770m acquisition of Cadent Therapeutics
In a bold move to strengthen its neuroscience division, Swiss pharmaceutical giant Novartis has agreed to acquire Cadent Therapeutics, a US-based neuroscience company, in a ... Read More
Novartis acquires Vedere Bio to advance optogenetic gene therapy for vision restoration
In a significant acquisition that could reshape the landscape of gene therapy for vision restoration, Swiss pharmaceutical giant Novartis has acquired Vedere Bio, a US-based ... Read More
Novartis to acquire IFM Tre with eye on immunomodulatory drugs
Novartis acquisition of IFM Tre : Novartis has signed a deal worth up to $1.575 billion to acquire US biopharma company IFM Tre from IFM ... Read More
Blackstone Life Sciences and Novartis launch Anthos Therapeutics to target high-risk cardiovascular diseases
In a strategic partnership aimed at advancing cardiovascular treatments, Blackstone Life Sciences has teamed up with Swiss pharmaceutical giant Novartis to create Anthos Therapeutics, a ... Read More